Ken Griffin’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$373K Buy
28,680
+22,337
+352% +$291K ﹤0.01% 4385
2025
Q1
$67.2K Sell
6,343
-7,334
-54% -$77.7K ﹤0.01% 5283
2024
Q4
$232K Sell
13,677
-62,177
-82% -$1.06M ﹤0.01% 4750
2024
Q3
$1.76M Buy
75,854
+54,222
+251% +$1.26M ﹤0.01% 2621
2024
Q2
$527K Sell
21,632
-145,462
-87% -$3.54M ﹤0.01% 3731
2024
Q1
$5.64M Buy
167,094
+166,727
+45,430% +$5.63M ﹤0.01% 1672
2023
Q4
$11.6K Sell
367
-147,506
-100% -$4.65M ﹤0.01% 5509
2023
Q3
$3.78M Buy
147,873
+25,962
+21% +$663K ﹤0.01% 1849
2023
Q2
$3.5M Sell
121,911
-192,878
-61% -$5.53M ﹤0.01% 1970
2023
Q1
$7.55M Buy
314,789
+11,483
+4% +$275K ﹤0.01% 1497
2022
Q4
$5.14M Buy
303,306
+112,903
+59% +$1.91M ﹤0.01% 1772
2022
Q3
$2.82M Buy
190,403
+126,867
+200% +$1.88M ﹤0.01% 2398
2022
Q2
$1M Sell
63,536
-34,097
-35% -$537K ﹤0.01% 3395
2022
Q1
$2.63M Buy
97,633
+82,316
+537% +$2.22M ﹤0.01% 2707
2021
Q4
$567K Sell
15,317
-56,420
-79% -$2.09M ﹤0.01% 4452
2021
Q3
$3.43M Buy
+71,737
New +$3.43M ﹤0.01% 2413
2021
Q2
Sell
-190,621
Closed -$7.87M 6380
2021
Q1
$7.87M Buy
190,621
+152,371
+398% +$6.29M ﹤0.01% 1642
2020
Q4
$1.66M Sell
38,250
-271,999
-88% -$11.8M ﹤0.01% 2762
2020
Q3
$13.3M Sell
310,249
-388,035
-56% -$16.6M ﹤0.01% 957
2020
Q2
$32.6M Buy
698,284
+683,546
+4,638% +$31.9M 0.01% 547
2020
Q1
$200K Buy
14,738
+1,805
+14% +$24.5K ﹤0.01% 4083
2019
Q4
$141K Buy
+12,933
New +$141K ﹤0.01% 4223
2017
Q2
Sell
-14,302
Closed -$114K 3621
2017
Q1
$114K Buy
+14,302
New +$114K ﹤0.01% 3302
2016
Q4
Sell
-2,085
Closed -$36K 3551
2016
Q3
$36K Buy
+2,085
New +$36K ﹤0.01% 3334
2016
Q2
Hold
0
3339
2016
Q1
Sell
-676
Closed -$30K 3306
2015
Q4
$30K Buy
+676
New +$30K ﹤0.01% 3538
2015
Q3
Sell
-149
Closed -$7K 3986
2015
Q2
$7K Sell
149
-1,946
-93% -$91.4K ﹤0.01% 3722
2015
Q1
$83K Buy
2,095
+1,244
+146% +$49.3K ﹤0.01% 3289
2014
Q4
$22K Buy
+851
New +$22K ﹤0.01% 3572
2014
Q3
Hold
0
3508